ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,123, issued on June 17, was assigned to H. Lundbeck A/S (Valby, Denmark).
"Agent, uses and methods for treatment" was invented by Lars Christian Biilmann Ronn (Valby, Denmark), Ibrahim John Malik (Valby, Denmark), Jeffrey B. Stavenhagen (Valby, Denmark), Soren Christensen (Valby, Denmark), Jan Egebjerg (Valby, Denmark), Arnout Gerritsen (Utrecht, Netherlands), Edward van den Brink (Utrecht, Netherlands), Paul Parren (Utrecht, Netherlands) and Rob de Jong (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level...